Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Research|March 8, 2000
Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancyC Capparelli, P J Kostenuik, S Morony, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 29, 2003
Skeletal muscle adaptations to microgravity exposure in the mouseB C Harrison, D L Allen, B Girten, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 27, 2007
Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone diseaseY Y Yuan, P J Kostenuik, M S Ominsky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosisB Bolon, C Carter, M Daris, et al.
Calcified Tissue International|May 10, 2008
Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in miceS A J Lloyd, Y Y Yuan, P J Kostenuik, et al.
The Journal of Experimental Medicine|August 22, 2000
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesisH Min, S Morony, I Sarosi, et al.
Calcified Tissue International|December 20, 2005
The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidismJ Padagas, M Colloton, V Shalhoub, et al.
Genes & Development|June 6, 1998
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcificationN Bucay, I Sarosi, C R Dunstan, et al.
Nature|February 9, 1999
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisY Y Kong, H Yoshida, I Sarosi, et al.
Gut|December 14, 2004
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerinF R Byrne, S Morony, K Warmington, et al.
Pageof 3